follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

J&J says it sells final stake in Elan for $332M

Source: Bloomberg

Back to Top Comments Email Print

Latest News

advertisement

Johnson & Johnson sold 25.4 million shares of Elan Corp. ending a relationship started four years ago to develop the Alzheimer's disease drug bapineuzumab.

Continue Reading »»

Share This Story On:
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top